- Home
- LWLG vs OCUL Comparison
LWLG vs OCUL Comparison
Compare LWLG & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LWLG | OCUL |
|---|---|---|
| Founded | 1991 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.8B |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | LWLG | OCUL |
|---|---|---|
| Price | $10.14 | $8.25 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $23.56 |
| AVG Volume (30 Days) | ★ 7.2M | 2.5M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.79 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $236,855.00 | ★ $1,990,000.00 |
| Revenue This Year | N/A | $7.93 |
| Revenue Next Year | N/A | $96.07 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 147.74 | 3.48 |
| 52 Week Low | $1.09 | $6.23 |
| 52 Week High | $18.71 | $16.44 |
Technical Indicators
Market Signals| Indicator | LWLG | OCUL |
|---|---|---|
| Relative Strength Index (RSI) | 40.76 | 42.38 |
| Support Level | $3.46 | $7.62 |
| Resistance Level | $18.49 | $9.93 |
| Average True Range (ATR) | 1.37 | 0.46 |
| MACD | -0.30 | -0.02 |
| Stochastic Oscillator | 3.43 | 24.47 |
Price Performance
Historical ComparisonAbout LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a specialty materials and intellectual property company focused on the development and commercialization of proprietary electro-optic (EO) polymer materials designed to enable high-speed optical modulators for data communications and other photonic applications. Its Perkinamine family of EO polymers is designed for integration into silicon photonics (SiPh) and other photonic integrated circuit (PIC) platforms, supporting high-speed optical modulation with lower drive voltage requirements compared with some conventional silicon-based and III-V compound semiconductor approaches. The company operates as a single reportable segment.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.